Lucid Diligence Brief: Helio Genomics and Syneos Health Deal
Lucid Diligence Brief: Helio Genomics and Syneos Health Deal to expand…
Lucid Diligence Brief: Iterative Health Acquisition of NextStage Cardiology Research Sites
Lucid Diligence Brief: Iterative Health Acquisition of NextStage Cardiology…
Lucid Diligence Brief: Roche to acquire PathAI
Lucid Diligence Brief: Roche acquires PathAI for USD 1.05B to advance AI…
Lucid Diligence Brief: Axoft $55 million Series A
Lucid Diligence Brief: Axoft $55 million Series A Professional audiences only.…
Lucid Diligence Brief: Viz.ai and Johnson & Johnson collaboration on AI-powered subdural hemorrhage care
Lucid Diligence Brief: Viz.ai and Johnson & Johnson collaboration on…
AAAAI 2026 Preview: Key Allergy, Asthma and Immunology Highlights to Watch
AAAAI 2026 at a Glance Get ready for AAAAI 2026. LucidQuest’s preview brings…
ESGO 2026 Preview: Key Gynaecological Oncology Highlights to Watch
ESGO 2026 at a Glance Get ready for ESGO 2026. LucidQuest’s preview brings…
ECCO 2026 Preview: Key Crohn’s and Colitis Highlights to Watch
ECCO 2026 at a Glance Get ready for ECCO 2026. LucidQuest’s preview brings…
Lucid Diligence Brief: Ubie and Mayo Clinic's digital front door partnership
Lucid Diligence Brief: Ubie and Mayo Clinic's digital front door partnership…
Healthcare and Pharma Industry Trends H2 2025: From Innovation to Execution
An in-depth analysis of pharma and healthcare industry trends in H2 2025,…
Lucid Diligence Brief: Iambic Takeda AI drug discovery collaboration
Lucid Diligence Brief: Iambic Takeda AI drug discovery collaboration…
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled rare-disease therapeutics
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled…